Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Biology Reports|August 7, 2014
Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patientsFeng Liu, Xiaobin Mei, Yingying Zhang, et al.
Frontiers in Immunology|October 17, 2019
Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 InflammasomeShaofei Wang, Jiajun Fan, Xiaobin Mei, et al.
Clinical and Translational Medicine|February 26, 2021
IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injuryWei Chen, Yilan Shen, Jiajun Fan, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 10, 2018
Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasomeTao Ding, Shaofei Wang, Xuyao Zhang, et al.
ACS Applied Materials & Interfaces|January 11, 2019
Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver DiseaseWenjing Zai, Wei Chen, Zimei Wu, et al.
Applied Microbiology and Biotechnology|February 27, 2023
A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activationYilan Shen, Yuqing Xu, Pei Shen, et al.
Journal for Immunotherapy of Cancer|December 13, 2019
Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancerXuyao Zhang, Yichen Wang, Jiajun Fan, et al.
Cell Death & Disease|July 21, 2017
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activationShaofei Wang, Yubin Li, Jiajun Fan, et al.
Acta Pharmaceutica Sinica. B|February 3, 2021
VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responsesYilan Shen, Wei Chen, Lei Han, et al.
Applied Microbiology and Biotechnology|May 2, 2020
Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responsesYilan Shen, Xin Jin, Wei Chen, et al.
Pageof 3